Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dalian Zhen-Ao Bio-Tech is a global leader in the production of ribonucleic acid (RNA), nucleotides (including all five major types), high-nucleotide yeast extracts, and related biologics. Their products are widely used as nutritional enhancers in infant formula, food flavoring agents (umami/kokumi boosters), animal feed supplements, and healthcare products. The company has over four decades of experience with advanced fermentation/extraction technology. It supplies three out of the world’s top five infant formula brands and exports to more than 30 countries[1][2][3][4]. Its best-selling nucleic acid capsule is certified by international sports organizations[1].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dalian Zhen-Ao Bio-Tech.